D Niederwieser

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP)

J. Esteve, M. Labopin, J. Finke, 2005, Leukemia.

Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

J Hermans, A. Gratwohl, D. Niederwieser, 2000, Blood.

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

J Hermans, G. Gahrton, A. Gratwohl, 1998, Lancet.

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

A Ferrant, D. Niederwieser, J. Goldman, 1995, Blood.

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

R M Stone, R. Larson, H. Dombret, 2008, Leukemia.

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

W. Wiktor-Jedrzejczak, N. Kröger, J. Finke, 2014, Bone Marrow Transplantation.